Key result
Planned RCT tests low- versus medium-intensity brisk walking for post-PCI VO2 peak and adherence.
Why the study?
Cardiac rehabilitation is critical after PCI for CHD, but participation and adherence are unexpectedly poor; the comparative benefit of low- versus medium-intensity brisk walking on attendance, adherence, and physical results remains unknown.
Does low-intensity brisk walking compared with medium-intensity brisk walking improve cardiorespiratory endurance (VO2 peak) and cardiac rehabilitation adherence in low-risk patients with coronary heart disease after PCI?
RCT (n=108)
Single-blind (outcome assessors, laboratory technicians, data managers, and statisticians blinded; participants and clinical data collectors unblinded)
1:1 ratio using IBM SPSS Statistics V.26.0 with sealed, opaque envelopes
No
Does low-intensity brisk walking compared with medium-intensity brisk walking improve cardiorespiratory endurance (VO2 peak) and cardiac rehabilitation adherence in low-risk patients with coronary heart disease after PCI?
This study protocol outlines a randomized controlled trial designed to determine whether low-intensity or medium-intensity home-based brisk walking supervised via WeChat achieves better adherence and cardiorespiratory fitness in post-PCI patients.
Answers are grounded in this paper and cite their sources.
Optimal brisk walking intensity for post-PCI adherence and VO2 peak remains undetermined; this RCT will provide direct evidence.
Introduction Cardiac rehabilitation (CR) is a critical treatment for patients with coronary heart disease after percutaneous coronary intervention. Unfortunately, participation and adherence of CR are unexpectedly poor. This study aims to test whether low-intensity or medium-intensity brisk walking is more helpful in improving early attendance, adherence and physical results. Methods and analysis This randomised controlled study will compare the effects of low-intensity and medium-intensity brisk walking to improve adherence and cardiopulmonary endurance. Participants will be randomly allocated to low-intensity or medium-intensity groups and will be followed-up for 8 weeks. Primary and secondary outcome data will be collected at baseline and at 2, 4 and 8 weeks. Primary outcomes measure changes in oxygen consumption (VO 2 ) peak value (mL/kg/min), as well as adherence. Secondary outcomes include changes in body mass index, oxygen pulse, maximal metabolic equivalent, breathing reserve, vital capacity, ratio of forced expiratory volume in 1 s to forced vital capacity, Δoxygen consumption/Δwork rate (ΔVO 2 /ΔWR), minute ventilation/carbon dioxide production and self-efficacy. Ethics and dissemination Ethical approval and informed consent form have been obtained from the Ethics Committee of Hebei General Hospital (approval number: NA-2021–03). The study background and main objective, as well as potential benefits and risks, will be fully explained to the participants and their families. Findings from this study will be published on academic journals in Chinese or in English for widespread dissemination of the results Trial registration number ChiCTR2100047568.
No takes yet. Share an insight, caveat, or question.
Piao et al. (2022) conducted an RCT in Coronary heart disease after percutaneous coronary intervention (n=108). Low-intensity brisk walking with WeChat support vs. Medium-intensity brisk walking (30-40 minutes targeting 60%-75% of maximum heart rate, 3 days a week) with WeChat support was evaluated on Changes in peak oxygen consumption (VO2 peak, mL/kg/min) and exercise adherence rate at 2, 4, and 8 weeks. Low-intensity versus medium-intensity brisk walking over 8 weeks is being evaluated in a planned RCT of 108 post-PCI patients to assess VO2 peak and adherence (study protocol, no results yet).
Synapse has enriched 10 related papers. Consider them for comparative context: